Propranolol therapy for cerebral cavernous malformations

Detalhes bibliográficos
Autor(a) principal: Lopes-Coelho, Filipa
Data de Publicação: 2022
Outros Autores: Nunes, Sofia, Martins, Filipa, Hipolito, Ana, Gouveia-Fernandes, Sofia, Domingues, Germana, Melo, Bernardete F., Sacramento, Joana F., Conde, Sílvia V., Pereira, Sofia A., Vinhais, Sofia, Salgado, Duarte, Serpa, Jacinta
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/137780
Resumo: Funding Information: The present study was funded by IPOLFG EPE and by iNOVA4Health (UID/Multi/04462/2019) a program finan‑ cially supported by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência, through national funds. The PhD fellowship of FLC was funded by FCT (PD/BD/128337/2017).
id RCAP_fe82c30f0fe6b32c7fc834e127e4041b
oai_identifier_str oai:run.unl.pt:10362/137780
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Propranolol therapy for cerebral cavernous malformationsangiogenesiscerebral cavernous malformationendothelial cellsmonocytespropranololMedicine(all)Biochemistry, Genetics and Molecular Biology(all)Immunology and Microbiology(all)Funding Information: The present study was funded by IPOLFG EPE and by iNOVA4Health (UID/Multi/04462/2019) a program finan‑ cially supported by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência, through national funds. The PhD fellowship of FLC was funded by FCT (PD/BD/128337/2017).Cerebral cavernous malformations (CCMs) are vascular malformations characterized by the abnormal growth of vascular structures in the central nervous system. However, the precise mechanism(s) responsible for the development of CCM vascular abnormalities remain poorly understood. Although the mechanisms of action of propranolol in CCM have not yet been fully explored it is not commonly prescribed, it has been shown to be effective in children and appears to play a protective role in the prevention of CCM-derived hemorrhage in adults. The present study performed in vitro and ex vivo assays in order to examine the effects of propranolol on endothelial cells (ECs). The percentage of CD14+/CD31+ cells and the levels of VEGF in the peripheral blood (PB) of a child patient with CCM, with recurrent seizures and hemorrhages, who was maintained under propranolol therapy, were also analyzed. In addition to the effects of propranolol on differentiated ECs, and the decrease angiogenic-related features in vitro and ex vivo, it was observed that in the PB of this patient, propranolol administration decreased the percentage of circulating cells sharing monocytic and EC features (CD14+/CD31+ cells), as well as the VEGF levels; this was concomitant with a good prognosis and with the reversion of CCM lesions. A decrease in VEGF levels by propranolol may also be involved in the impairment of the recruitment of CD14+/CD31+ monocytes functioning as endothelial progenitor cells to sustain the vascular lesion. On the whole, the present study demonstrates that propranolol impairs angiogenesis in vitro and may thus be a useful tool for the clinical management of CCM. Moreover, the present study highlights the monitorization of the levels of CD14+/CD31+ monocytes and VEGF levels as a useful tool for predicting the clinical efficacy of propranolol in patients with CCM.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNLopes-Coelho, FilipaNunes, SofiaMartins, FilipaHipolito, AnaGouveia-Fernandes, SofiaDomingues, GermanaMelo, Bernardete F.Sacramento, Joana F.Conde, Sílvia V.Pereira, Sofia A.Vinhais, SofiaSalgado, DuarteSerpa, Jacinta2022-05-11T22:48:19Z2022-04-062022-04-06T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/137780eng2632-2900PURE: 43678743https://doi.org/10.3892/wasj.2022.158info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:15:13Zoai:run.unl.pt:10362/137780Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:48:53.502022Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Propranolol therapy for cerebral cavernous malformations
title Propranolol therapy for cerebral cavernous malformations
spellingShingle Propranolol therapy for cerebral cavernous malformations
Lopes-Coelho, Filipa
angiogenesis
cerebral cavernous malformation
endothelial cells
monocytes
propranolol
Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)
title_short Propranolol therapy for cerebral cavernous malformations
title_full Propranolol therapy for cerebral cavernous malformations
title_fullStr Propranolol therapy for cerebral cavernous malformations
title_full_unstemmed Propranolol therapy for cerebral cavernous malformations
title_sort Propranolol therapy for cerebral cavernous malformations
author Lopes-Coelho, Filipa
author_facet Lopes-Coelho, Filipa
Nunes, Sofia
Martins, Filipa
Hipolito, Ana
Gouveia-Fernandes, Sofia
Domingues, Germana
Melo, Bernardete F.
Sacramento, Joana F.
Conde, Sílvia V.
Pereira, Sofia A.
Vinhais, Sofia
Salgado, Duarte
Serpa, Jacinta
author_role author
author2 Nunes, Sofia
Martins, Filipa
Hipolito, Ana
Gouveia-Fernandes, Sofia
Domingues, Germana
Melo, Bernardete F.
Sacramento, Joana F.
Conde, Sílvia V.
Pereira, Sofia A.
Vinhais, Sofia
Salgado, Duarte
Serpa, Jacinta
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
RUN
dc.contributor.author.fl_str_mv Lopes-Coelho, Filipa
Nunes, Sofia
Martins, Filipa
Hipolito, Ana
Gouveia-Fernandes, Sofia
Domingues, Germana
Melo, Bernardete F.
Sacramento, Joana F.
Conde, Sílvia V.
Pereira, Sofia A.
Vinhais, Sofia
Salgado, Duarte
Serpa, Jacinta
dc.subject.por.fl_str_mv angiogenesis
cerebral cavernous malformation
endothelial cells
monocytes
propranolol
Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)
topic angiogenesis
cerebral cavernous malformation
endothelial cells
monocytes
propranolol
Medicine(all)
Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)
description Funding Information: The present study was funded by IPOLFG EPE and by iNOVA4Health (UID/Multi/04462/2019) a program finan‑ cially supported by Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência, through national funds. The PhD fellowship of FLC was funded by FCT (PD/BD/128337/2017).
publishDate 2022
dc.date.none.fl_str_mv 2022-05-11T22:48:19Z
2022-04-06
2022-04-06T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/137780
url http://hdl.handle.net/10362/137780
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2632-2900
PURE: 43678743
https://doi.org/10.3892/wasj.2022.158
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138089179807744